Form D · Biotechnology
Vali Nanomedical Corp
Los Angeles, CA · CIK 0001654505
Offering snapshot reported Oct 2, 2015 · SEC filing
- Reported sold
- $250K Offering amount: $250K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $250K Reported outside-investor minimum
- First sale
- Sep 21, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 2, 2015 | Initial | $250,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-248638
Convertible promissory notes convertible into equity securities of the Issuer.
Source: Form D, filed Oct 2, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andrew Gray | Director, Executive, Promoter |
| Pin Wang | Director, Promoter |
| Michael Kk Wong | Director, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3638 Mountain View Avenue
Los Angeles, CA, 90066
Los Angeles, CA, 90066